Drug Discovery & Development

Mesenchymal stem cells with high levels of extracellular vesicle secretion promote vascular regeneration and improve heart function in mice.

Off-the-shelf and custom plasmid DNA and viral vector products help scientists take their gene therapy research to the next level.

Scientists need to be aware of many factors to build accurate and reproducible serial dilution protocols. 

Learn how immunotherapy is revolutionizing autoimmune disorder treatment.

In this webinar, Junguk Park and Vanda Lopes will discuss luciferase-based reporter cell lines that assess cytokine signaling, GPCR signaling, and enzyme activity.

Optimizing nonviral genetic engineering of resting T cells for improved cancer immunotherapy

A modern take on supercritical fluid chromatography separates fact from fiction.

Take a deep dive into the latest advances for gathering, integrating, and leveraging multiomics data for biomarker discovery.

Standardized quality materials and reagents help scientists improve cell and gene therapy production.

In this webinar, Elizabeth Proctor will discuss the latest organoid models that scientists use to advance human disease research, with a focus on promoting drug discovery and precision medicine.

A streamlined protocol for generating iNK cells from PSC spheroids

Industry expertise helps scientists navigate and streamline antibody-drug conjugate research and development.

As a trailblazer in rare disease research and treatment, Wendy Chung captures the big picture of rare disease genetics with the help of next generation sequencing.

In this webinar, Alli Lynch presents the fundamentals and applications of ultrafiltration in the laboratory setting. 

The Sapio Partner Program ensures services partners are certified in the deployment and support of Sapio's lab informatics platform.

Human cells repair RNA breaks induced by a programmable CRISPR system, paving the way for temporary treatments for genetic diseases.

In this webinar, Daryl Cole will highlight how new technologies improve antibody discovery and production.

To accelerate research initiatives, scientists can utilize a platform that brings together over 14 petabytes of multimodal data. 

By tinkering with branched mRNA structures, scientists lay the groundwork to build better vaccines in the future.